Oral Anticoagulant Monitoring by Laboratory or Near-Patient Testing: What a Clinician Should Be Aware Of

 

 Buy Article Permissions and Reprints

ABSTRACT

Prothrombin time (PT) is the primary laboratory test for monitoring oral anticoagulant treatment but is influenced by preanalytical conditions and analytical variables, that is, thromboplastin reagents and instrumentation. Standardization and normalization of test results is mandatory. PT results should be transformed to International Normalized Ratio (INR) by calibration of the reagent/instrument system with International Reference standards according to World Health Organization guidelines. However, there is still uncertainty in the INR that is caused in part by calibration errors and in part by interaction between the PT reagent and various factors in the patient's specimen. These problems are highlighted in INR measurements performed with whole blood coagulation monitors. Each center should maintain an appropriate scheme of internal and external quality control for the laboratory INR measurement as well as the individual point-of-care coagulation monitors used by the center and patients for self-testing.

REFERENCES

• 1 Hirsh J, Dalen J E, Anderson D R, Poller L, Bussey H, Ansell J, Deykin D. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Chest . 2001;  119 8S-21S
  PubMedGoogle Scholar
• 2 WHO Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to monitor oral anticoagulant therapy. World Health Organization Technical Report Series, 1999; No. 889
• 3 van den Besselaar A H P M, Aillaud M F, Denson K WE. et al . Influence of three types of automated coagulometers on the international sensitivity index (ISI) of rabbit, human and recombinant human tissue factor preparations.  Thromb Haemost . 1999;  81 66-70
  PubMedGoogle Scholar
• 4 Poller L, van den Besselaar A H P M, Jespersen J, Tripodi A, Houghton D. The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometers effects on the ISI of ECAA thromboplastins.  Thromb Haemost . 1998;  80 615-623
  PubMedGoogle Scholar
• 5 Johnston M, Harrison L, Moffat K, Willan A, Hirsh J. Reliability of the international normalized ratio for monitoring the induction phase of warfarin: comparison with the prothrombin time ratio.  J Lab Clin Med . 1996;  128 214-217
  CrossrefPubMedGoogle Scholar
• 6 Hyers T M, Agnelli G, Hull R D, Morris T A, Samama M, Tapson V, Weg J G. Antithrombotic therapy for venous thromboembolic disease.  Chest . 2001;  119 176S-193S
  CrossrefPubMedGoogle Scholar
• 7 van den Besselaar A H P M, Meeuwisse-Braun J. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.  Blood Coag Fibrinol . 1993;  4 635-638
  PubMedGoogle Scholar
• 8 Tripodi A. The risk of heparin-neutralizing substances.  Am J Clin Pathol . 1999;  111 566
  PubMedGoogle Scholar
• 9 Della Valle P, Crippa L, Safa O. et al . Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants.  Ann Med Intern . 1996;  147 10-14
  PubMedGoogle Scholar
• 10 Moll S, Ortel T L. Monitoring warfarin therapy in patients with lupus anticoagulants.  Ann Intern Med . 1997;  127 177-185
  CrossrefPubMedGoogle Scholar
• 11 Lawrie A S, Purdy G, Mackie I J, Machin S J. Monitoring oral anticoagulation therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.  Br J Haematol . 1997;  98 887-892
  CrossrefPubMedGoogle Scholar
• 12 Robert A, Le Querrec A, Delahousse B. et al . Control of oral anticoagulation in patients with the antiphospholipid syndrome. Influence of the lupus anticoagulant on international normalized ratio.  Thromb Haemost . 1998;  80 99-103
  PubMedGoogle Scholar
• 13 Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci P M. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins.  Br J Haematol . 2001;  115 672-678
  CrossrefPubMedGoogle Scholar
• 14 Rapaport S I, Le D T. Thrombosis in the antiphospholipid antibody syndrome.  N Engl J Med . 1995;  333 665
  CrossrefPubMedGoogle Scholar
• 15 Lassen J F, Brandslund I, Antonsen S. International Normalized Ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements.  Clin Chem . 1995;  41 444-447
  PubMedGoogle Scholar
• 16 Jacobs P. Concentration of citrate anticoagulant.  Am J Clin Pathol . 1973;  60 941
  PubMedGoogle Scholar
• 17 Chantarangkul V, Tripodi A, Clerici M, Negri B, Mannucci P M. Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations.  Thromb Haemost . 1998;  80 258-262
  PubMedGoogle Scholar
• 18 Lottin L, Woodhams B J, Saureau M C, Robert A, Aillaud M F, Arnaud E, Martinoli J L. The clinical relevance of the citrate effect on International Normalized Ratio determinations depends on the reagent and instrument combination used. Blood Coagul Fibrinolysis .  2001;  12 399-404
  PubMedGoogle Scholar
• 19 van den Besselaar A H P M, Chantarangkul V, Tripodi A. A comparison of two sodium citrate concentrations in two evacuated blood collection systems for prothrombin time and ISI determination.  Thromb Haemost . 2000;  84 664-667
  PubMedGoogle Scholar
• 20 van den Besselaar A H P M, van Dam W, Sturk A, Bertina R M. Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes.  Thromb Haemost . 2001;  85 647-650
  PubMedGoogle Scholar
• 21 Vadher B D, Lloyd M, Parker N, Patterson D LH. Effect of sample storage on the International Normalized Ratio.  Br J Haematol . 1997;  97 936-937
  PubMedGoogle Scholar
• 22 Hernández A G, Martín de Segovia M J, Villanueva J R. Refrigerated stored specimens are not reliable for delayed INR determination.  Br J Haematol . 1997;  98 781-782
  PubMedGoogle Scholar
• 23 Froom P, Abramova D, Bar-El M, Barak M. Reliability of delayed prothrombin time INR determinations in a central laboratory using off-site blood sampling.  Clin Lab Haematol . 2001;  23 189-192
  CrossrefPubMedGoogle Scholar
• 24 Baglin T, Luddington R. Reliability of delayed INR determination: implications for decentralized anticoagulant care with off-site blood sampling.  Br J Haematol . 1997;  96 431-434
  CrossrefPubMedGoogle Scholar
• 25 Brigden M L, Graydon C, McLeod B, Lesperance M. Prothrombin time determination. The lack of need for a discard tube and 24-hour stability.  Am J Clin Pathol . 1997;  108 422-426
  PubMedGoogle Scholar
• 26 Ridyard J, Bhavnani M, Seal L H. Laboratory control of oral anticoagulant therapy: preservation of prothrombin time specimens using a polypropylene collection system.  Clin Lab Haematol . 1998;  20 369-372
  CrossrefPubMedGoogle Scholar
• 27 Leeming D R, Craig S, Stevenson K J, Taberner D A. The determination of INR in stored whole blood.  J Clin Pathol . 1998;  51 360-363
  PubMedGoogle Scholar
• 28 Woodhams B, Girardot O, Blanco M J, Colesse G, Gourmelin Y. Stability of coagulation proteins in frozen plasma.  Blood Coagul Fibrinolysis . 2001;  12 229-236
  CrossrefPubMedGoogle Scholar
• 29 Poller L, Keown M, Shepherd S A, Shiach C R, Tabeart S. The effects of freeze drying and freeze drying additives on the prothrombin time and the international sensitivity index.  J Clin Pathol . 1999;  52 744-748
  PubMedGoogle Scholar
• 30 van den Besselaar A H P M. Precision and accuracy of the International Normalized Ratio in oral anticoagulant control.  Haemostasis . 1996;  26 248-265
  PubMedGoogle Scholar
• 31 Preston F E. Quality control and oral anticoagulation.  Thromb Haemost . 1995;  74 515-520
  PubMedGoogle Scholar
• 32 van den Besselaar A H P M. Field study of lyophilised plasmas for local prothrombin time calibration in the Netherlands.  J Clin Pathol . 1997;  50 371-374
  PubMedGoogle Scholar
• 33 Loeliger E A, van den Besselaar A H P M, Lewis S M. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.  Thromb Haemost . 1985;  53 148-154
  PubMedGoogle Scholar
• 34 Tomenson J A. A statistician's independent evaluation. In: van den Besselaar AMHP, Gralnick HR, Lewis SM, eds. Thromboplastin Calibration and Oral Anticoagulant Control Boston, MA: Martinus Nijhoff 1984: 87-108
  Google Scholar
• 35 Attermann J. Monitoring oral anticoagulant therapy: measuring coagulant activity. Ph.D. thesis. Faculty of Health Sciences, University of Aarhus, 2000
  Google Scholar
• 36 Macik B G. Designing a point-of-care program for coagulation testing.  Arch Pathol Lab Med . 1995;  119 929-938
  PubMedGoogle Scholar
• 37 Ruzicka K, Kapiotis S, Quehenberger P. et al . Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguChek Plus;rM in various clinical settings.  Thromb Res . 1997;  87 431-440
  CrossrefPubMedGoogle Scholar
• 38 Kitchen S, Preston F E. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins.  J Clin Pathol . 1997;  50 951-956
  CrossrefPubMedGoogle Scholar
• 39 van den Besselaar A H P M, Breddin K, Lutze G. et al . Multicenter evaluation of a new capillary blood prothrombin time monitoring system.  Blood Coagul Fibrinolysis . 1995;  6 726-732
  PubMedGoogle Scholar
• 40 Andrew M, Ansell J L, Becker D M. et al . Point-of-care prothrombin time measurement for professional and patient self-testing use.  Am J Clin Pathol . 2001;  115 288-296
  CrossrefPubMedGoogle Scholar
• 41 Zweig S E, Meyer B G, Sharma S. et al . Membrane-based, dry-reagent prothrombin time tests.  Biomed Instrum Technol . 1996;  30 245-256
  PubMedGoogle Scholar
• 42 Tripodi A, Arbini A A, Chantarangkul V. et al . Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio?.  Thromb Haemost . 1993;  70 921-924
  PubMedGoogle Scholar
• 43 Tripodi A, Chantarangkul V, Mannucci P M. Near-patient testing devices to monitor oral anticoagulant therapy.  Br J Haematol . 2001;  113 847-852
  CrossrefPubMedGoogle Scholar
• 44 Poller L, Keown M, Chauhan N. et al . European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems.  Br J Haematol . 2002;  116 844-850
  CrossrefPubMedGoogle Scholar
• 45 Attermann J, Kynde K, Hasenkam J M. Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer.  Thromb Res . 1998;  92 287-291
  CrossrefPubMedGoogle Scholar
• 46 Taborski U, Müller-Berghaus G. State-of-the-art patient self-management for control of oral anticoagulation.  Semin Thromb Hemost . 1999;  25 43-47
  PubMedGoogle Scholar
• 47 Havrda D E, Hawk T L, Marvin C M. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic.  Ann Pharmacother . 2002;  36 769-774
  CrossrefPubMedGoogle Scholar
• 48 van den Besselaar A H P M. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation.  J Thromb Thrombolysis . 2001;  12 35-40
  CrossrefPubMedGoogle Scholar
• 49 Bland J M, Altman D G. Comparing methods of measurement: why plotting difference against standard method is misleading.  Lancet . 1995;  346 1085-1087
  CrossrefPubMedGoogle Scholar
• 50 Gosselin R, Owings J T, White R H. et al . A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.  Thromb Haemost . 2000;  83 698-703
  PubMedGoogle Scholar
• 51 Biasiolo A, Rampazzo P, Furnari O, Filippi B, Pengo V. Comparison between routine laboratory prothrombin time measurements and fingerstick determinations using a near-patient testing device (Pro-Time;rM).  Thromb Res . 2000;  97 495-498
  CrossrefPubMedGoogle Scholar
• 52 Fairweather R B, Ansell J, van den Besselaar A H P M. et al . College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. Laboratory monitoring of oral anticoagulant therapy.  Arch Pathol Lab Med . 1998;  122 768-781
  PubMedGoogle Scholar
• 53 Mörsdorf S, Erdlenbruch W, Taborski U. et al . Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspects.  Semin Thromb Hemost . 1999;  25 109-115
  PubMedGoogle Scholar
• 54 Poller L, Keown M, Chauhan N. et al . European Concerted Action on Anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors.  Clin Chem . 2002;  48 255-260
  PubMedGoogle Scholar